• where experts go to learn about FDA
  • Miscellaneous

    • HP&M Attorney to Speak at CBI Paragraph IV Disputes ConferenceOctober 5th, 2010

      Hyman, Phelps & McNamara, P.C.’s Kurt R. Karst will be speaking at the Center for Business Intelligence’s (“CBI’s”) 3rd Annual Life Sciences Congress on Paragraph IV Disputes, which is scheduled for October 18-19, 20109 at the Hilton Alexandria Old Town in Alexandria, Virginia.  This popular …

    • California’s Green Chemistry Regulations; A Lot of R&R (Requirements and Responsibilities) for Regulated IndustrySeptember 28th, 2010

      By Randy Pollack*, Wes Siegner & Brian J. Donato – In September 2008, California Governor Arnold Schwarzenegger signed landmark green chemistry legislation authorizing the Department of Toxic Substance Control (“DTSC”) to: (1) identify and prioritize chemicals of concern, evaluate alternatives as well as to specify regulatory …

    • HP&M Presents the Evolution of FDA and the Park DoctrineSeptember 21st, 2010

      Join Hyman, Phelps & McNamara, P.C. attorneys on October 8, 12:00 p.m. – 1:30 p.m. for a free webinar on a very important, timely topic.  You can register for the free webinar here.  (Please register by September 29th.) In criminal prosecutions of corporate executives, ignorance of …

    • U.S. News & World Report Ranks HP&M as Top Tier FDA Law FirmSeptember 20th, 2010

      Hyman, Phelps & McNamara, P.C. (“HP&M”) is proud to announce that the inaugural “Best Law Firms” survey by U.S. News & World Report has ranked HP&M as a “Tier 1” law firm in the area of FDA Law.  Only six firms made it to the top …

    • We’re Looking for a Repeat; Nominate FDA Law Blog for the ABA Blawg 100September 14th, 2010

      It’s that time of year again when the Blawggeratti (legal bloggers) are all atwitter about the American Bar Association’s (“ABA’s”) Blawg 100 – the top 100 legal blogs in the blogosphere.  With your help we made the top 100 list last year, and we are …

    • HHS Seeks Input on Potential Benefits and Risks of Synthetic BiologyAugust 31st, 2010

      By Ricardo Carvajal – According to one working definition, synthetic biology encompasses "the design and fabrication of biological components and systems that do not already exist in the natural world" and "the re-design and fabrication of existing biological systems."  Recent developments in the field prompted …

    • Hyman, Phelps & McNamara, P.C. Welcomes New Director, Karla PalmerAugust 12th, 2010

      Hyman, Phelps & McNamara, P.C. is pleased to announce that Karla L. Palmer will join the Firm as a Director on Monday. Karla brings significant experience in civil and administrative litigation matters. At Hyman, Phelps & McNamara, she will focus on a wide range of …

    • HP&M Attorney Elected to USP Expert CommitteeJuly 14th, 2010

      Hyman, Phelps & McNamara, P.C. (“HP&M”) is pleased to announce that Diane B. McColl has been elected to  the U.S. Pharmacopeial Convention’s (“USP’s”) Expert Committee for the Food Chemicals Codex (Monographs – Food Ingredients) for the 2010-2015 cycle.  The committee develops new monographs and revises …

    • HP&M Attorney Elected to USP Board of TrusteesJune 29th, 2010

      Hyman, Phelps & McNamara, P.C. (“HP&M”) is pleased to announce that Frank J. Sasinowski has been elected by the the U.S. Pharmacopeial Convention (“USP”) as an At-Large Trustee of the USP Board of Trustees for the 2010-2015 cycle.  The Board of Trustees will guide the activities …

    • FTC Delays Enforcement of the Red Flags Rule…AgainMay 28th, 2010

      By William T. Koustas – As we have previously reported (here, here, and here), the FTC has delayed enforcement of its Red Flags Rule (“the Rule”) several times since its original effective date of November 1, 2008.  Now, some in Congress have requested that the …

    • FDA’s Regulation of Nanotech: a Change in the Wind?May 19th, 2010

      By Ricardo Carvajal – FDA’s approach to regulation of nanotechnology has remained essentially unchanged since the issuance of the agency’s Nanotechnology Task Force Report in 2007.  In that report, which was endorsed by then-Commissioner von Eschenbach, FDA declined to adopt a formal definition of nanotechnology, …

    • FDA Law Blog Turns 3!March 5th, 2010

      Yep, it’s been three years since we started FDA Law Blog.  And that means it’s time again to take a minute from blogging on FDA issues to pat ourselves on the back.  It’s been a banner year for us.  We recently topped 800 posts (almost …

    • What are the Benefits and Risks of Having a Lawyer Testify About Legal Advice Previously Provided to a Client about FDA Matters?January 31st, 2010

      For heavily-regulated companies, such as those regulated by the Food and Drug Administration, it is common for companies to seek advice from in-house and outside counsel regarding whether proposed conduct would violate the law. It has become increasingly popular for federal prosecutors to target the …

    • Senators Pryor and Cardin introduce the Nanotechnology Safety Act of 2010January 24th, 2010

      By Ricardo Carvajal – According to a press release issued by Senator Mark Pryor's office, Senator Pryor (D-AR) has teamed up with Senator Benjamin Cardin (D-MD) to introduce the Nanotechnology Safety Act of 2010.  The bill, introduced on January 21, 2010 as S. 2942, is …

    • In Memoriam – Stephen H. McNamaraDecember 28th, 2009

      Our colleague and friend, Stephen H. McNamara passed away on December 28, 2009 of complications from cancer at the age of 66.  Steve is survived by Caroline, his wife of 43 years, and his children, Matthew (Veronica) McNamara, and Deborah  (Nicholas) Hutchins and six grandchildren.  Steve was …